The Cancer Vaccine Institute at UW Medicine in Seattle, Wash., is a collaboration of scientists, doctors, nurses, patients and philanthropists, all determined to eliminate cancer. Our mission is to diagnose, prevent and treat this disease by developing immune system-based approaches, ones that bring the power of precision medicine and cancer immunology out of the lab and into the lives of people with cancer or at high risk for cancer.
We are especially focused on developing vaccines to prevent cancers responsible for millions of deaths and enormous healthcare costs — breast, colon, ovarian, prostate, pancreatic and lung cancers — and to prevent cancer relapse. Cancer vaccines are ideally suited to both primary and secondary cancer prevention.
Mary L. (Nora) Disis, M.D.
Director, UW Medicine Cancer Vaccine Institute
Athena Distinguished Professor of Breast Cancer Research
Dr. Disis was educated at the University of Nebraska Medical School, the University of Illinois College of Medicine and UW Medicine-Fred Hutchinson Cancer Research Center. She was one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen, and she holds several patents in the field of targeted cancer therapy and cancer diagnostics. In addition, she serves as the inaugural editor-in-chief of JAMA Oncology. Read more about Dr. Disis.
In the News
- UW Medicine, Seattle, WA (Nov 2017): Scientists and Donors Create Community — and Cancer Vaccines
- Inlander, Spokane, WA (Sep 2017): Killing Cancer - Vaccines are on the way to help battle the disease and prevent relapses
- Q13 Fox News Seattle (Apr 2017): TVG's Dr. Salazar discusses how NIH funding cuts will negatively impact cancer research
- Seattle Magazine (Feb 2017): Dr. Disis voted one of Seattle's Top Doctors in 2017!